9779 related articles for article (PubMed ID: 1445665)
1. A gelonin-containing immunotoxin directed against human breast carcinoma.
Rosenblum MG; Zuckerman JE; Marks JW; Rotbein J; Allen WR
Mol Biother; 1992 Sep; 4(3):122-9. PubMed ID: 1445665
[TBL] [Abstract][Full Text] [Related]
2. A specific and potent immunotoxin composed of antibody ZME-018 and the plant toxin gelonin.
Rosenblum MG; Murray JL; Cheung L; Rifkin R; Salmon S; Bartholomew R
Mol Biother; 1991 Mar; 3(1):6-13. PubMed ID: 1906286
[TBL] [Abstract][Full Text] [Related]
3. An immunotoxin composed of a monoclonal antitransferrin receptor antibody linked by a disulfide bond to the ribosome-inactivating protein gelonin: potent in vitro and in vivo effects against human tumors.
Scott CF; Goldmacher VS; Lambert JM; Jackson JV; McIntyre GD
J Natl Cancer Inst; 1987 Nov; 79(5):1163-72. PubMed ID: 3500356
[TBL] [Abstract][Full Text] [Related]
4. Use of blue-sepharose for purification of immunotoxin containing type 1 ribosome-inactivating protein, gelonin.
Masuda K; Hirano K; Takagishi Y
Biomed Chromatogr; 1994; 8(1):9-13. PubMed ID: 7510554
[TBL] [Abstract][Full Text] [Related]
5. c-erbB-2/p185-directed therapy in human lung adenocarcinoma.
Snider JM; Bushnell LJ; Chen LC; Lanza LA
Ann Thorac Surg; 1996 Nov; 62(5):1454-9. PubMed ID: 8893583
[TBL] [Abstract][Full Text] [Related]
6. Immunotoxins to a human melanoma-associated antigen: comparison of gelonin with ricin and other A chain conjugates.
Sivam G; Pearson JW; Bohn W; Oldham RK; Sadoff JC; Morgan AC
Cancer Res; 1987 Jun; 47(12):3169-73. PubMed ID: 3495329
[TBL] [Abstract][Full Text] [Related]
7. An immunotoxin composed of monoclonal anti-Thy 1.1 antibody and a ribosome-inactivating protein from Saponaria officinalis: potent antitumor effects in vitro and in vivo.
Thorpe PE; Brown AN; Bremner JA; Foxwell BM; Stirpe F
J Natl Cancer Inst; 1985 Jul; 75(1):151-9. PubMed ID: 3859688
[TBL] [Abstract][Full Text] [Related]
8. Immunotoxins composed of monoclonal antibody to alpha-fetoprotein and gelonin as a potent hepatoma-targeted drug delivery system.
Masuda K; Takahashi K; Nagata S; Hirano K; Takagishi Y
J Drug Target; 1994; 2(4):323-31. PubMed ID: 7532086
[TBL] [Abstract][Full Text] [Related]
9. Prevention of growth of leukemia cells in mice by monoclonal antibodies directed against Thy 1.1 antigen disulfide linked to two ribosomal inhibitors:pokeweed antiviral protein or ricin A chain.
Ramakrishnan S; Houston LL
Cancer Res; 1984 Apr; 44(4):1398-404. PubMed ID: 6142765
[TBL] [Abstract][Full Text] [Related]
10. Wortmannin, a phosphoinositide 3-kinase inhibitor, selectively enhances cytotoxicity of receptor-directed-toxin chimeras in vitro and in vivo.
Davol PA; Bizuneh A; Frackelton AR
Anticancer Res; 1999; 19(3A):1705-13. PubMed ID: 10470104
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics in the rat of a panel of immunotoxins made with abrin A chain, ricin A chain, gelonin, and momordin.
Wawrzynczak EJ; Cumber AJ; Henry RV; May J; Newell DR; Parnell GD; Worrell NR; Forrester JA
Cancer Res; 1990 Dec; 50(23):7519-26. PubMed ID: 2253201
[TBL] [Abstract][Full Text] [Related]
12. Comparative cytotoxicity and pharmacokinetics of antimelanoma immunotoxins containing either natural or recombinant gelonin.
Rosenblum MG; Marks JW; Cheung LH
Cancer Chemother Pharmacol; 1999; 44(4):343-8. PubMed ID: 10447583
[TBL] [Abstract][Full Text] [Related]
13. A potent and specific immunotoxin for tumor cells expressing disialoganglioside GD2.
Mujoo K; Reisfeld RA; Cheung L; Rosenblum MG
Cancer Immunol Immunother; 1991; 34(3):198-204. PubMed ID: 1756537
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxicity of gelonin conjugated to targeting molecules: effects of weak amines, monensin, adenovirus, and adenoviral capsid proteins penton, hexon, and fiber.
Goldmacher VS; Blättler WA; Lambert JM; McIntyre G; Stewart J
Mol Pharmacol; 1989 Nov; 36(5):818-22. PubMed ID: 2531272
[TBL] [Abstract][Full Text] [Related]
15. Suppression of an epidermal growth factor receptor-hyperproducing tumor by an immunotoxin conjugate of gelonin and a monoclonal anti-epidermal growth factor receptor antibody.
Hirota N; Ueda M; Ozawa S; Abe O; Shimizu N
Cancer Res; 1989 Dec; 49(24 Pt 1):7106-9. PubMed ID: 2555059
[TBL] [Abstract][Full Text] [Related]
16. Properties of immunotoxins against a glycolipid antigen associated with Burkitt's lymphoma.
Wiels J; Junqua S; Dujardin P; Le Pecq JB; Tursz T
Cancer Res; 1984 Jan; 44(1):129-33. PubMed ID: 6690030
[TBL] [Abstract][Full Text] [Related]
17. Potentiation of antiproliferative effects of monoclonal antibody Lym-1 and immunoconjugate Lym-1-gelonin on human Burkitt's lymphoma cells with gamma-interferon and tumor necrosis factor.
O'Boyle KP; Colletti D; Mazurek C; Wang Y; Ray SK; Diamond B; Rosenblum MG; Epstein AL; Shochat D; Dutcher JP
J Immunother Emphasis Tumor Immunol; 1995 Nov; 18(4):221-30. PubMed ID: 8680650
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of the specific cytotoxicity of a breast cancer-associated antigen immunotoxin by the carboxylic ionophore monensin.
Griffin TW; Pagnini PG; Houston LL
J Biol Response Mod; 1987 Oct; 6(5):537-45. PubMed ID: 3500277
[TBL] [Abstract][Full Text] [Related]
19. Therapy of human T-cell acute lymphoblastic leukaemia with a combination of anti-CD7 and anti-CD38-SAPORIN immunotoxins is significantly better than therapy with each individual immunotoxin.
Flavell DJ; Boehm DA; Noss A; Warnes SL; Flavell SU
Br J Cancer; 2001 Feb; 84(4):571-8. PubMed ID: 11207056
[TBL] [Abstract][Full Text] [Related]
20. Antigen-specific activity of carcinoma-reactive BR64-doxorubicin conjugates evaluated in vitro and in human tumor xenograft models.
Trail PA; Willner D; Lasch SJ; Henderson AJ; Greenfield RS; King D; Zoeckler ME; Braslawsky GR
Cancer Res; 1992 Oct; 52(20):5693-700. PubMed ID: 1382845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
